CARBONIC ANYDRASE INHIBITORS
- Summary
- Carbonic anhydrase inhibitors and their use as chemosensitizing agents in the treatment of cancers
- Technology Benefits
- These compounds can potentially be useful in treating resistant cancers such as glioblastoma, by revesring the resistance to currently used drugs
- Technology Application
- Cancer therapy
- Detailed Technology Description
- Compounds are provided which are inhibitors of the CAXII enzyme. Due to the interaction between CAXII and Pgp, such compounds may be useful in lowering the chemoresistance of a cancer allowing for co-treatment with existing anti-cancer agents.
- Type of Cooperation
- Licensing
- Application Date
- 12/05/2017 00:00:00
- Application No.
- 2017203184
- Country/Region
- Australia
For more information, please click Here
